AWS Health Innovation Podcast

Perspectum enables non-invasive "virtual biopsies" that provide safer, more accessible disease monitoring for conditions like liver disease, diabetes, and cancer.

Happiest Baby's SNOO Smart Sleeper is an FDA-approved cradle that tracks baby's sleep, sends alerts, and automatically soothes with womb-like motions.

PhaseV is pioneering the use of reinforcement learning, causal ML, and adaptive trial design to optimize resource utilization and time efficiency in drug development.

MDI Health has developed an innovative AI solution used by payers and value-based providers to optimize medication management, identify high-risk patients, and reduce overall healthcare expenditure.

Ikerian is pioneering the use of non-invasive retinal imaging and AI to identify biomarkers that can predict disease progression and treatment response.

Ibex AI's Galen™ platform demonstrated outstanding outcomes in clinical studies and helps pathologists and providers reduce diagnostic errors, implement real-time quality control, reduce diagnosis time and boost productivity.

Zoundream's solution uses AI to analyze infant cries and sounds in real-time, pinpointing reasons such as hunger or tiredness with remarkable accuracy, and detecting early signs of conditions like autism.

Featuring Mendel, Akrivia Health, Epistemix, Ovation, and Evidation Health, this episode explores how innovative companies are leveraging real-world data and AI to drive precision medicine, uncover new treatments, and improve population health outcomes.

Explore how CareJourney, Aidoc, Forward, CLEW, and Thyme Care leverage cutting-edge technologies to optimize clinician and patient experiences, driving better outcomes and transforming healthcare delivery.

Featuring Deep6 AI, Lokavant, and Science 37, this episode explores how these companies are leveraging AI, data analytics, and decentralized models to revolutionize clinical trial recruitment, operations, and patient accessibility.

Explore how Us2.AI, Truvian Health, and Sparta Science leverage AI, cloud, and novel biological insights to revolutionize diagnostics and biomarker discovery, enabling accessible and precise care pathways.

Dive into the groundbreaking approaches of companies like VivoDyne, Seer, Ordaos, Insilico Medicine, and Alchemab, who are pushing boundaries in drug R&D through microfluidic bioengineering, proteome mapping, AI-driven drug design, and resilient antibody discovery.

Mendel enables life sciences to index patient journeys at scale and learn from them at the speed of real-time dialogues. The journey started in 2017 from a two-person office in Silicon Valley with commitment to building novel technology and not to be another “Boy Who Cried Wolf” AI company. To do that, we have invested 4 years and millions of dollars in R&D before launching our first model in 2020...

Vivodyne, a biotech firm employing bottom-up self-assembly principles to grow complex tissues that better mimic human physiology, enabling the study of systemic effects like immune responses and linking multiple tissue systems.

Iktos is an innovative company specializing in the development of artificial intelligence solutions applied to chemical research and new drug design, enabling major productivity gains in upstream pharmaceutical R&D.

DeepLife uses machine learning to curate and annotate single-cell RNA-seq datasets, enabling downstream bioinformatics analysis and target identification.

LabVoice develops a hands-free voice assistant that provides a common human-lab interaction for scientists, enabling voice-assisted workflows and hands-free access to lab software and data.

Ordaōs, a human-enabled machine-driven drug design company leveraging GenAI and AI/ML to design and build mini proteins as therapeutics for biomedical research and drug discovery.

CareJourney provides healthcare analytics solutions that leverage claims data to enable value-based care delivery organizations, hospitals, health plans, and life sciences companies to improve care quality and reduce costs.

Quin Wills, Co-Founder & CSO of Ochre Bio, joins us to discuss their use of deep analysis of liver genetics and precision RNA design to develop new therapies for liver diseases like hepatitis, cirrhosis and liver cancer.

Bluesight's software platform connects data across medication manufacturing, ordering, inventory, dispensing and administration to help hospital pharmacies reduce costs, ensure compliance and improve safety. Kevin shares how this unprecedented visibility enables customers to reduce waste, ensure compliance and detect drug diversion.

Prospection is a healthcare analytics company that converts data into actionable insights by applying machine learning to hundreds of millions of patient histories to predict future health events years in advance.

Akrivia Health provides research data, clinical trial optimization, and molecular characterization for mental health and dementia. We speak with David Newton, COO & Co-Founder of Akrivia Health, about how they use AI to process free text notes into structured data, all while safeguarding patient privacy.

Vim is building an ecosystem to connect healthcare applications and workflows. Co-founder and CEO Oron Afek shares the story behind Vim's evolution into a healthcare "app store" now reaching over 20 million patients.

Scispot offers a no-code workflow automation platform for BioTechs to digitize and automate their workflows. The company's platform automates mundane administrative tasks, centralizes company-wide data, templatizes routine research and collaborative documentation, enabling companies to make processes more efficient and reproducible.